hiPSC-derived bone marrow milieu identifies a clinically actionable driver of niche-mediated treatment resistance in leukemia

Deepali Pal*, Helen J. Blair, Jessica Parker, Sean Hockney, Melanie Beckett, Mankaran Singh, Ricky Tirtakusuma, Ryan Nelson, Hesta McNeill, Sharon Hanmy Angel, Aaron Wilson, Salem Nizami, Sirintra Nakjang, Shalini Sankar, Peixun Zhou, Claire Schwab, Paul B. Sinclair, Lisa J. Russell, Jonathan Coxhead, Christina HalseyJames M. Allan, Christine J. Harrison, Anthony Vincent Moorman, Heidenreich Olaf, Josef Vormoor

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

9 Downloads (Pure)

Fingerprint

Dive into the research topics of 'hiPSC-derived bone marrow milieu identifies a clinically actionable driver of niche-mediated treatment resistance in leukemia'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology